Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Equine Healthcare Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
5.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
5.2.3. By Activity (Sports/Racing, Recreation, Others)
5.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
5.2.5. By Region
5.2.6. By Company (2022)
5.3. Product Market Map
5.3.1. By Product
5.3.2. By Indication
5.3.3. By Activity
5.3.4. By Distribution Channel
5.3.5. By Region
6. North America Equine Healthcare Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
6.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
6.2.3. By Activity (Sports/Racing, Recreation, Others)
6.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Equine Healthcare Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Indication
6.3.1.2.3. By Activity
6.3.1.2.4. By Distribution Channel
6.3.2. Canada Equine Healthcare Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Indication
6.3.2.2.3. By Activity
6.3.2.2.4. By Distribution Channel
6.3.3. Mexico Equine Healthcare Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Indication
6.3.3.2.3. By Activity
6.3.3.2.4. By Distribution Channel
7. Europe Equine Healthcare Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
7.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
7.2.3. By Activity (Sports/Racing, Recreation, Others)
7.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Equine Healthcare Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Indication
7.3.1.2.3. By Activity
7.3.1.2.4. By Distribution Channel
7.3.2. United Kingdom Equine Healthcare Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Indication
7.3.2.2.3. By Activity
7.3.2.2.4. By Distribution Channel
7.3.3. France Equine Healthcare Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Indication
7.3.3.2.3. By Activity
7.3.3.2.4. By Distribution Channel
7.3.4. Italy Equine Healthcare Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Indication
7.3.4.2.3. By Activity
7.3.4.2.4. By Distribution Channel
7.3.5. Spain Equine Healthcare Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Indication
7.3.5.2.3. By Activity
7.3.5.2.4. By Distribution Channel
8. Asia-Pacific Equine Healthcare Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
8.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
8.2.3. By Activity (Sports/Racing, Recreation, Others)
8.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Equine Healthcare Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Indication
8.3.1.2.3. By Activity
8.3.1.2.4. By Distribution Channel
8.3.2. Japan Equine Healthcare Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Indication
8.3.2.2.3. By Activity
8.3.2.2.4. By Distribution Channel
8.3.3. India Equine Healthcare Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Indication
8.3.3.2.3. By Activity
8.3.3.2.4. By Distribution Channel
8.3.4. Australia Equine Healthcare Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Indication
8.3.4.2.3. By Activity
8.3.4.2.4. By Distribution Channel
8.3.5. South Korea Equine Healthcare Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Indication
8.3.5.2.3. By Activity
8.3.5.2.4. By Distribution Channel
9. South America Equine Healthcare Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
9.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
9.2.3. By Activity (Sports/Racing, Recreation, Others)
9.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Equine Healthcare Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Indication
9.3.1.2.3. By Activity
9.3.1.2.4. By Distribution Channel
9.3.2. Argentina Equine Healthcare Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Indication
9.3.2.2.3. By Activity
9.3.2.2.4. By Distribution Channel
9.3.3. Colombia Equine Healthcare Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Indication
9.3.3.2.3. By Activity
9.3.3.2.4. By Distribution Channel
10. Middle East and Africa Equine Healthcare Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
10.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
10.2.3. By Activity (Sports/Racing, Recreation, Others)
10.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Equine Healthcare Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Indication
10.3.1.2.3. By Activity
10.3.1.2.4. By Distribution Channel
10.3.2. Saudi Arabia Equine Healthcare Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Indication
10.3.2.2.3. By Activity
10.3.2.2.4. By Distribution Channel
10.3.3. UAE Equine Healthcare Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Indication
10.3.3.2.3. By Activity
10.3.3.2.4. By Distribution Channel
10.3.4. Kuwait Equine Healthcare Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Product
10.3.4.2.2. By Indication
10.3.4.2.3. By Activity
10.3.4.2.4. By Distribution Channel
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Porter’s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. Competitive Landscape
14.1. Business Overview
14.2. Product Offerings
14.3. Recent Developments
14.4. Financials (As Reported)
14.5. Key Personnel
14.6. SWOT Analysis
14.6.1. Zoetis Inc.
14.6.2. Boehringer Ingelheim GmbH
14.6.3. Merck & Co., Inc.
14.6.4. Hallmarq Veterinary Imaging Ltd
14.6.5. Esaote SpA
14.6.6. Vetoquinol SA
14.6.7. IDEXX Laboratories, Inc.
14.6.8. Dechra Pharmaceuticals PLC
15. Strategic Recommendations
16. About Us & Disclaimer